Financial statements Ra-Pharm W Likwidacji
Balance sheet data of RA-PHARM W LIKWIDACJI
|
Year
|
2020
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 233 170,84 | 237 081,53 | 227 515,62 |
| A. Fixed assets | 215 000,00 | 200 000,00 | 100 000,00 |
| B. Current assets | 18 170,84 | 37 081,53 | 127 515,62 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
| Total liabilities | 233 170,84 | 237 081,53 | 227 515,62 |
| A. Equity | -54 484,82 | -72 487,22 | -96 903,64 |
| B. Liabilities and provisions for liabilities | 287 655,66 | 309 568,75 | 324 419,26 |
| I. Long-term liabilities | - | - | - |
| II. Short-term liabilities | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.